Abits
ABTS
Ebang International
EBON
Bit Origin
BTOG
SATO TECHNOLOGIES CORP
CCPUF
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
ZVSA ZyVersa Therapeutics
- 1.2200
- +0.0800+7.02%
Trading Dec 23 14:03 ET
2.86MMarket Cap-0.06P/E (TTM)
1.2305High1.1289Low63.60KVolume1.1880Open1.1400Pre Close76.34KTurnover2.72%Turnover Ratio0.00P/E (Static)2.34MShares25.000052wk High0.41P/B2.85MFloat Cap0.980152wk Low--Dividend TTM2.34MShs Float8750.0000Historical High--Div YieldTTM8.91%Amplitude0.9800Historical Low1.2000Avg Price1Lot Size
ZyVersa Therapeutics Key Stats
EPS
According to the latest financial report of ZyVersa Therapeutics, the latest earnings per share (TTM) for the company is -2.43. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about ZyVersa Therapeutics's free cash flow? The latest report shows it as -644.40K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ZyVersa Therapeutics shows that the company's current ratio is 0.03, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ZyVersa Therapeutics, the quick ratio is 0.01, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of ZyVersa Therapeutics? The latest ROE figure is -30.69%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ZyVersa Therapeutics, the total asset return on investment (ROA) is -12.35%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ZyVersa Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ZyVersa Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.